Dr. Peter Hotez: ‘The FDA and CDC really had no choice’ but to pause Johnson & Johnson vaccine
03:16
Share this -
copied
Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine, joins Ali Velshi to discuss the "pause" on the Johnson & Johnson vaccine in the United States after the discovery of 6 rare cases of blood clotting in women who were immunized with the shot. The goal, says Hotez, is to identify a specific group who might be at higher risk, and that requires a little time. “Even though the U.S. Has other options, many countries don't. For many countries, all they have are the J & J, AstraZeneca vaccine and the Russian Sputnik V vaccine,” all of which are non-mNRA and have the potential to behave similarly. Says Hotez, “It is critical to sort this out not only to protect American citizens, but to protect the world.”April 17, 2021
UP NEXT
Why VP Kamala Harris’ Visit to Planned Parenthood Is So Historic – Even For Dems
04:43
Supreme Court: self-preservation at democracy’s expense, says Kermit Roosevelt
04:11
Joy Reid: Civil Rights icon Myrlie Evers’ sense of 'disappointment' at the slow progress of civil rights
11:20
The long history of U.S. intervention in Haiti
04:54
Gaza entrepreneurs want youth to play a role in Gaza’s future
11:33
Exploring Haitian culture and the American Dream with 'American Street' by Ibi Zoboi